Professional Documents
Culture Documents
For several years, marijuana has been known to have antiemetic effects
(relieve nausea) to treat the side effects of cancer treatment chemotherapy.
However, a study shows that marijuana has a greater potential in the treatment of
cancer. Manuel Guzman's research published in the 2003, Journal of Nature
Review states that in in-vivo (mouse) and in-vitro (besides organism)
experiments, cannabinoid compounds have the effect of inhibiting tumor cell
growth and can even kill it by triggering apoptosis (self-destructive cells).
Furthermore, THC (Tetrahydrocannabinol) in marijuana has also been shown to
trigger selective apoptosis only in blood cancer cells (leukemia) within a period of
six hours. THC compounds influencing the certain gene, which helps stop the
communication process in cells associated with the defence system of tumour
cells. In simple explanation, marijuana can weaken the defence of tumor cells for
the human immune system.
Some studies show that cannabinoids can help reduce symptoms due to
diabetes. In a study published in the Journal of Autoimmunity, injection of 5 mg
of cannabidiol every day can reduce the incidence of diabetes in mice. As many as
86% of mice that did not get cannabidiol intake had diabetes, and only 30% of the
group of mice had diabetes when got cannabidiol. Scientists found mouse that
were not given cannabidiol had diabetes on average at week 17th, while the
majority of mouse given the cannabidiol did not have diabetes until week 26th.
While the allocation of cannabidiol in a study published in the American Journal
of Pathology in 2006 states that marijuana substance significantly reduces the risk
of diabetic mouse suffering from oxygen deficiency in the eye so that blood filters
to the retina break down - which is the main cause of blindness in diabetics.
The use of marijuana for the treatment of epilepsy has existed since the
11th century. A study published in the New England Journal of Medicine states
that oils from marijuana extracts have been shown to reduce seizures in epilepsy.
Cannabidiol is one of the compounds in marijuana that can cut the average
monthly seizure rate from 12.4 to 5.9 in 52 children with Dravet syndrome who
consumed the extract for 14 weeks of the study period. Dravet's syndrome is a
form of severe epilepsy that causes sufferers to experience seizures constantly,
thus triggering cognitive problems to the risk of premature death. Unlike THC,
which has a high "marijuana" effect when consumed, cannabidiol has no
psychoactive properties. Devinsky said that cannabidiol binds to receptors in the
brain that can reduce nerve cell stimulation that causes seizures. In addition,
Cannabidiol is not addictive and does not cause motion sickness.
The use of marijuana is indeed quite controversial. Its existence was
considered illegal and included in illegal drugs. On the other hand, actually this
plant which thrives in Indonesia is a medicine that has quite a number of health
benefits. With proper processing and use of marijuana can reduce the symptoms
of the disease and even become a cure for various diseases such as epilepsy,
diabetes, and cancer.
Work Cited
Sanmartin, Paul E., and Kamil Detyniecki. "Cannabidiol for epilepsy: new hope
on the horizon?." Clinical therapeutics 40.9 (2018): 1438-1441.